Antisynaptosome antibodies affect synaptosomal permeability to neurotransmitters.
D000613:Aminobutyrates / Q000378:metabolism; D000818:Animals; D000906:Antibodies; D001921:Brain / Q000166:cytology / Q000378:metabolism; D002247:Carbon Isotopes; D002463:Cell Membrane Permeability; D003165:Complement System Proteins / Q000494:pharmacology; D005971:Glutamates / Q000378:metabolism; D007106:Immune Sera / Q000494:pharmacology; D009411:Nerve Endings / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D009435:Synaptic Transmission; D013572:Synaptic Vesicles / Q000378:metabolism*; D013574:Synaptosomes / Q000276:immunology / Q000378:metabolism; D014316:Tritium
D000613:Aminobutyrates; D000906:Antibodies; D002247:Carbon Isotopes; D005971:Glutamates; D007106:Immune Sera; D014316:Tritium; D012701:Serotonin; D010042:Ouabain; D003165:Complement System Proteins; D009638:Norepinephrine